´
R. Fernandez de la Pradilla et al. / Tetrahedron 62 (2006) 2684–2692
2690
2.40 (s, 3H, CH3–p-Tol), 3.33 (dt, 1H, JZ7.9, 5.4 Hz, H-10),
3.67 (d, 1H, JZ8.0 Hz, H-3), 5.43 (dt, 1H, JZ15.6, 1.5 Hz,
H-100), 5.72 (dt, 1H, JZ15.6, 6.8 Hz, H-200), 7.28 (d, 2H, JZ
7.8 Hz, ArH), 7.46 (d, 2H, JZ8.3 Hz, ArH). 13C NMR
(75 MHz) d 13.5, 13.8, 21.5, 21.8, 22.5, 26.8, 33.0, 34.5,
64.6, 69.8, 76.5, 115.1, 125.4 (2C), 129.5 (2C), 136.7,
141.4, 142.2. IR (CCl4): 3360, 2920, 2900, 2820, 1630,
1470, 1440, 1240, 1070, 1000, 770 cmK1. Data for 11a,b (as
an inseparable 44:56 mixture of diastereomers): RfZ0.46
(50% Et2O–hexane). 1H NMR (400 MHz) d 0.88 (t, 3H, JZ
7.3 Hz, CH3), 0.92–1.0 (m, 9H, CH3), 1.23–1.70 (m, 20H),
3.08 (td, 1H, JZ5.9, 1.9 Hz), 3.20–3.26 (m, 3H), 3.39 (d,
1H, JZ1.9 Hz, CH–CO), 3.47 (d, 1H, JZ1.9 Hz, CH–CO),
3.58 (d, 1H, JZ4.8 Hz, CH–CO), 3.77 (d, 1H, JZ4.8 Hz,
CH–CO). 13C NMR (125 MHz) d 13.7, 13.9, 19.1, 19.7,
22.3, 22.4, 26.7, 27.2, 27.8, 28.3, 28.4, 31.4, 31.5, 33.6,
33.7, 56.0, 56.4, 58.6, 58.7, 59.1, 59.3, 59.4, 211.7. IR
(CCl4): 2960, 2930, 2875, 1720, 1460, 1430, 1380, 1230,
1190, 1090, 1050, 1020, 880 cmK1. MS (EI): 212 [M]C,
169, 127, 97, 71, 55 (100%), 43, 41. Data for 11c: RfZ0.52
(50% Et2O–hexane). 1H NMR (400 MHz) d 0.90 (t, 3H, JZ
7.2 Hz), 0.96 (t, 3H, JZ7.2 Hz), 1.34–1.66 (m, 10H), 3.07
(tt, 1H, JZ5.6, 1.7 Hz), 3.16 (td, 1H, JZ5.6, 1.7 Hz), 3.30
(d, 1H, JZ1.9 Hz, CH–CO), 3.42 (d, 1H, JZ2.1 Hz,
CH–CO). 13C NMR (50 MHz) d 13.7, 13.9, 19.1, 22.3,
27.8, 31.5, 33.8, 56.8, 57.2, 57.3, 59.2, 211.7. IR (CCl4):
2960, 2930, 2875, 1720, 1460, 1430, 1380, 1230, 1190,
1090, 1050, 1020, 880 cmK1. MS (EI): 127, 97, 71, 55
(100%), 43, 41, 39. The data of 10 was identical to that
found before.
3.4.5. Synthesis of (D)-(2R,3R,10R,SS)-(E)-3-[10-(tert-
butyldimethylsilyloxy)-n-pentyl]-2-(1-pentenyl)-2-(p-
tolylsulfinyl)oxirane, 13, (2S,3S,10R)-(E)-3-[10-(tert-
butyldimethylsilyloxy)-n-pentyl]-2-(1-pentenyl)-2-(p-
tolylsulfonyl)oxirane, 12, (D)-(2R,3R,10R)-(E)-3-[10-
(tert-butyldimethylsilyloxy)-n-pentyl]-2-(1-pentenyl)-2-
(p-tolylsulfonyl)oxirane, 14. From KH (10.7 mg,
0.26 mmol) in THF (1.30 mL), t-BuOOH (33 mL, 30 mg,
0.26 mmol) and a solution of dienyl sulfoxide 4 (29 mg,
0.06 mmol) in THF (0.46 mL), according to the general
procedure (94 h), a 9:41:37:12 of sulfonyl oxiranes 12 and
14, sulfinyl oxirane 13 and starting material was obtained.
Purification by chromatography (5–15% EtOAc–CH2Cl2)
gave 11.3 mg (38%) of 13, 14 mg (44%) of an 82:18
inseparable mixture of 14 and 12 and 3.1 mg (11%) of
starting material, as colorless oils. Data for 13: RfZ0.45
1
(2!15% EtOAc–hexane). [a]2D0 C80.1 (c 1.11). H NMR
(300 MHz) d K0.06 (s, 3H, TBDMS), K0.02 (s, 3H,
TBDMS), 0.79 (t, 3H, JZ7.4 Hz), 0.85 (s, 9H, TBDMS),
0.87 (t, 3H, JZ7.2 Hz), 1.24–1.51 (m, 8H), 2.00 (q, 2H, JZ
6.8 Hz), 2.37 (s, 3H, CH3–p-Tol), 3.36 (dt, 1H, JZ8.0,
5.6 Hz, H-10), 3.60 (d, 1H, JZ7.9 Hz, H-3), 5.48 (d, 1H, JZ
15.5 Hz, H-100), 5.60 (dt, 1H, JZ15.5, 6.3 Hz, H-200), 7.24
(d, 2H, JZ7.9 Hz, ArH), 7.47 (d, 2H, JZ8.2 Hz, ArH). 13C
NMR (75 MHz) d K4.4, K4.2, 13.6, 14.0, 18.0, 21.5, 21.9,
22.7, 25.7 (3C), 26.3, 34.5, 35.1, 63.8, 68.2, 78.5, 117.1,
125.9 (2C), 129.3 (2C), 136.1, 140.7, 142.0. IR (CCl4):
2920, 2900, 2820, 1530, 1440, 1240, 1060, 990, 770 cmK1
.
Data for 12: RfZ0.48 (15% EtOAc–hexane). 1H NMR
(300 MHz) d K0.04 (s, 3H, TBDMS), 0.05 (s, 3H,
TBDMS), 0.76 (t, 3H, JZ7.3 Hz), 0.80–0.90 (m, 3H),
0.86 (s, 9H, TBDMS), 1.23–1.60 (m, 8H), 1.96 (q, 2H, JZ
6.3 Hz), 2.42 (s, 3H, CH3–p-Tol), 3.22 (dt, 1H, JZ8.1,
4.9 Hz, H-10), 3.77 (d, 1H, JZ8.2 Hz, H-3), 5.65 (dt, 1H,
JZ15.5, 7.0 Hz, H-200), 5.82 (d, 1H, JZ15.5 Hz, H-100),
7.29 (d, 2H, JZ8.4 Hz, ArH), 7.68 (d, 2H, JZ8.4 Hz, ArH).
Data for 14: RfZ0.37 (15% EtOAc–hexane). [a]2D0 C6.6 (c
0.83). 1H NMR (300 MHz) d K0.02 (s, 3H, TBDMS), 0.03
(s, 3H, TBDMS), 0.76 (t, 3H, JZ7.3 Hz), 0.80–0.90 (m,
3H), 0.86 (s, 9H, TBDMS), 1.22–1.39 (m, 6H), 1.52–1.56
(m, 2H), 1.99 (m, 2H), 2.41 (s, 3H, CH3–p-Tol), 3.30 (ddd,
1H, JZ7.9, 6.1, 5.3 Hz, H-10), 3.82 (d, 1H, JZ7.9 Hz, H-3),
5.55 (dt, 1H, JZ15.5, 7.0 Hz, H-200), 5.93 (dt, 1H, JZ15.5,
1.5 Hz, H-100), 7.29 (d, 2H, JZ8.7 Hz, ArH), 7.69 (d, 2H,
JZ8.3 Hz, ArH). 13C NMR (75 MHz) d K4.5, K4.1, 13.5,
14.0, 21.7, 21.8, 22.6, 25.7 (3C), 26.4, 29.7, 34.2, 35.1, 65.1,
67.6, 76.6, 116.5, 129.4 (2C), 129.5 (2C), 132.9, 140.8,
145.5. IR (CCl4): 2920, 2890, 2820, 1440, 1310, 1240,
1130, 1070, 1000, 640 cmK1. MS (APCI): 489 [MCNa]K,
244 (100%).
3.4.4. Synthesis of (D)-(2R,3R,10S,SS)-(E)-3-(10-hydroxy-
pentyl)-2-(1-pentenyl)-2-(p-tolylsulfinyl)oxirane, 15, (D)-
(2R,3R,10S)-(E)-3-(10-hydroxypentyl)-2-(1-pentenyl)-2-
(p-tolylsulfonyl)oxirane ent-10, (7R,8S)-6-oxadodecanyl-
4,7-bis-oxirane, ent-11a,b, (7S,8S)-6-oxado- decanyl-4,
7-bis-oxirane, ent-11c. From NaH (2.2 mg, 0.094 mmol)
in THF (0.47 ), t-BuOOH (12 mL, 11 mg, 0.094 mmol) and
a solution of dienyl sulfoxide 2 (7.5 mg, 0.023 mmol) in
THF (0.16 mL), according to the general procedure
(70 min), an 80:4:11:5 of sulfinyl oxirane 15, sulfonyl
oxirane ent-10, and bis oxiranes ent-11a,b and ent-11c,
was obtained. Purification by chromatography (5–50%
EtOAc–hexane) gave 5.4 mg (76%) of 15, 0.3 mg (4%) of
ent-10 and 0.5 mg (13%) of ent-11c and ent-11a,b as
colorless oils. Data for 15: RfZ0.25 (50% EtOAc–hexane).
[a]2D0 C48.9 (c 0.60). H NMR (300 MHz) d 0.80 (t, 3H,
1
JZ7.4 Hz), 0.87 (t, 3H, JZ7.2 Hz), 1.20–1.39 (m, 6H),
1.36–1.62 (m, 2H), 1.81 (d, 1H, JZ2.4 Hz, OH), 1.99 (qd,
2H, JZ7.0, 1.5 Hz), 2.39 (s, 3H, CH3–p-Tol), 3.35 (m, 1H,
H-10), 3.61 (d, 1H, JZ8.1 Hz, H-3), 5.40 (dt, 1H, JZ15.7,
1.5 Hz, H-100), 5.67 (dt, 1H, JZ15.7, 6.8 Hz, H-200), 7.26
3.4.6. Synthesis of (L)-(2S,3R,10S)-(E)-3-(10-hydroxy-
pentyl)-2-(1-pentenyl)-2-(p-tolylsulfonyl)oxirane, 17.
From NaH (3.7 mg, 0.15 mmol) in THF (0.80 mL),
t-BuOOH (19 mL, 17 mg, 0.15 mmol) and a solution of
dienyl sulfone 7 (13 mg, 0.038 mmol) in THF (0.26 mL),
according to the general procedure (55 min), sulfonyl
oxirane 17 was obtained. Purification by chromatography
(5–50% Et2O–hexane) gave 11 mg (82%) of 17, as a
colorless oil. Data for 17: RfZ0.28 (50% Et2O–hexane).
[a]2D0 K39.2 (c 0.76). 1H NMR (300 MHz) d 0.68 (t, 3H, JZ
7.4 Hz), 0.92 (t, 3H, JZ7.3 Hz), 1.18 (sext, 2H, JZ7.3 Hz),
1.34–1.54 (m, 4H), 1.65–1.69 (m, 2H), 1.81–1.90 (m, 2H),
(d, 2H, JZ7.9 Hz, ArH), 7.46 (d, 2H, JZ8.2 Hz, ArH). 13
C
NMR (50 MHz) d 13.5, 13.8, 21.5, 21.8, 22.5, 26.9, 33.0,
34.5, 64.5, 69.8, 78.8, 117.4, 126.1 (2C), 129.3 (2C), 135.6,
141.1, 142.3. IR (CCl4): 3350, 2920, 2890, 2820, 2840,
1730, 1540, 1470, 1450, 1380, 1240, 1070, 1000, 770,
640 cmK1. Anal. Calcd for C19H28O3S: C, 67.82; H, 8.39;
S, 9.53. Found: C, 67.65; H, 8.42; S, 9.44. The data for
ent-10, ent-11c and ent-11a,b was identical to that of their
enantiomers.